市场监管总局：“十四五”期间出台质量融资增信措施 助3万家企业获贷款超2000亿元

Group 1 - The State Administration for Market Regulation (SAMR) has established a fair competition review mechanism, reviewing 42,200 important policy measures and proposing amendments to 11,400 of them to prevent policies that are detrimental to the construction of a unified national market [10][12] - During the 14th Five-Year Plan period, the SAMR has handled nearly 50,000 cases of unfair competition, including 4,296 cases of online unfair competition, optimizing the competitive ecosystem of both online and offline markets [12][6] - The SAMR has implemented a series of measures to enhance the quality of enterprises, including the establishment of chief quality officers in 279,000 companies, resulting in an average annual revenue growth of 9.7% for small and micro enterprises involved in quality improvement initiatives [2][46] Group 2 - The SAMR has strengthened the regulation of food safety, handling 2.26 million food safety cases and maintaining a food safety compliance rate of over 99.4% for drug inspections [7][29] - The SAMR has revised key laws such as the Company Law and the Anti-Monopoly Law, enhancing the regulatory framework for market operations and increasing the enterprise credit index from 128.6 in 2020 to 161.61 in the first half of 2025 [6][10] - The SAMR has facilitated the establishment of a unified market by promoting regional market integration, achieving "one network for handling" across multiple provinces and cities, and implementing shared electronic certificate standards [12][11] Group 3 - The SAMR has focused on enhancing the quality of the pharmaceutical industry, approving 204 innovative drugs and 265 innovative medical devices during the 14th Five-Year Plan period, with a significant increase in the number of innovative drugs under research [35][52] - The SAMR has implemented a comprehensive reform of drug and medical device regulation, emphasizing the entire lifecycle of drug safety and quality, and has established a dynamic regulatory mechanism for drug safety risk assessment [34][52] - The SAMR has actively supported the development of quality standards, issuing over 13,000 national standards and leading the formulation of 1,079 international standards during the 14th Five-Year Plan period [38][40]